Investor Area

News

Announcements by type

  • Presentation

  • Corporate

  • Newsletter

  • Regulatory

  • Financial

  • Clinical

  • Reset

 
Wednesday, 23 September 2020

CLINUVEL Confirms AGM Date

CLINUVEL Confirms AGM Date

Download PDF
 
 
Wednesday, 16 September 2020

Change of Director’s Interest Notice

Appendix 3Y – Change of Director’s Interest Notice is available to download as PDF

Download PDF
 
 

First patient dosed in SCENESSE® DNA Repair Program Xeroderma pigmentosum (XP) patient receives SCENESSE® treatment In the search for a preventative treatment of skin cancers, including melanoma, it is imperative to understand and treat DNA damage caused by ultraviolet (UV) radiation. Following the treatment of a patient suffering from xeroderma pigmentosum (XP), a disease characterised […]

www.clinuvel.com.

Download PDF

 
 

Xeroderma pigmentosum (XP) patient receives SCENESSE® treatment CLINUVEL PHARMACEUTICALS LTD today announced that the first patient diagnosed with xeroderma pigmentosum (XP-C) has received SCENESSE® (afamelanotide 16mg).1 The Special Access Program of one patient is part of CLINUVEL’s DNA Repair Program. CLINUVEL is evaluating SCENESSE® in a staged clinical program to confirm the drug’s ability to […]

www.clinuvel.com.

Download PDF

 
 

Figure 1: CLINUVEL’s DNA Repair Program aims to confirm that intervention with SCENESSE® causes elimination of DNA damage (photoproducts) and regeneration of DNA. The diagram shows that SCENESSE® has been proven to protect skin from light (photoprotection) and shown to repair DNA damage. Since photoprotection and regeneration are necessary to reduce the risk of skin […]

www.clinuvel.com.

Download PDF

 
 

CLINUVEL progresses innovative DNA Repair Program Drug tested to protect skin and regenerate DNA, firstly in XP patients at 10,000-fold skin cancer risk Figure 1: CLINUVEL’s DNA Repair Program aims to confirm that intervention with SCENESSE® causes elimination of DNA damage (photoproducts) and regeneration of DNA. The diagram shows that SCENESSE® has been proven to […]

www.clinuvel.com.

Download PDF

 
 
Thursday, 10 September 2020

SCENESSE® in DNA Repair

CLINUVEL to confirm cellular DNA repair in rare disease xeroderma pigmentosum (XP) A separate media release – in simple non-technical terms – has been lodged outlining the aims and objectivesof the DNA Repair Program. CLINUVEL will post background information on XP to its social media channels:Twitter | Facebook | Instagram | LinkedIn EXECUTIVE SUMMARY CLINUVEL […]

Download PDF
 
 

On 27 August 2020 CLINUVEL released its Preliminary Financial Report for FY2020. CFO Darren Keamy and CEO and Managing Director Dr Philippe Wolgen speak with Head of Investor Relations, Malcolm Bull, following the results release. A corporate presentation was also released on 27 August and can be accessed here.

Download PDF
 
 
Tuesday, 01 September 2020

Proposed issue of Securities

Download PDF

Download PDF
 
 

CLINUVEL OPENS VALLAURIX R&D CENTRE IN SINGAPORE Bespoke Research & Development Centre to advance innovative pharmaceutical and OTC products The CLINUVEL Group today announced the opening of its state-of-the-art centralised Research & Development Centre in Singapore, operated by CLINUVEL subsidiary VALLAURIX PTE Ltd. The extensive bespoke analytical and biological laboratories and offices will house and […]

Download PDF
 
 

Opening of VALLAURIX R&D facilities in Singapore

Download PDF
 
 

Download PDF Previous Next

Download PDF
 
 
Thursday, 27 August 2020

CLINUVEL Declares Full Year Dividend

CLINUVEL Declares Full Year Dividend Dividend/Distribution – CUV

Download PDF
 
 
Thursday, 27 August 2020

CLINUVEL Full Year Results

CLINUVEL Full Year Results 2020

Download PDF
 
Friday, 09 October 2020

CLINUVEL Annual Report 2020

CLINUVEL’s Annual Report for the year ended 30 June 2020 is available to download here.

Download PDF
 
Friday, 09 October 2020

CLINUVEL Annual General Meeting 2020

CLINUVEL PHARMACEUTICALS LTD’s 2020 Annual General Meeting (AGM) will be held on Wednesday, 11 November 2020 at 06.00pm (Melbourne time). To comply with COVID19 requirements set out in Government restrictions on travel and public gatherings, …

Download PDF
 
Wednesday, 07 October 2020

SCIENTIFIC COMMUNIQUÉ VI

Despite government campaigns to curb increases, current statistics show the rate of skin cancer is escalating, particularly in regions with predominantly fair-skinned populations. Skin cancer diagnoses have increased considerably over the last five decades, at …

Download PDF
 
Tuesday, 06 October 2020

CLINUVEL News & Facts site live

Earlier this week CLINUVEL launched a new microsite, CLINUVEL News & Facts. The CLINUVEL News & Facts site gives an opportunity to explore and discuss the people, science and ideas that underpin CLINUVEL. Read more …

Download PDF
 
Monday, 28 September 2020

Kommuniqué V, 2020

Kommuniqué V, 2020

Download PDF
 
Wednesday, 23 September 2020

CLINUVEL Newsletter V

CLINUVEL Newsletter V, 2020

Download PDF
 
Thursday, 23 July 2020

Kommuniqué IV

Liebe Aktionäre, Freunde,Es stellt sich eine neue Welt dar, die darauf hinweist, dass das Virus nicht so leicht zu beseitigen sein wird. Waehrend wir es akzeptieren, einen Modus der Koexistenz zu finden, muessen wir für …

Download PDF
 
Wednesday, 22 July 2020

CLINUVEL Newsletter

Communiqué IV, 2020 – 22 July 2020 Dear shareholders, friends,As a new world presents itself indicating that the virus will not easily be eliminated as we are accepting to find a modus co-existentiae, albeit we …

Download PDF
 
Thursday, 21 May 2020

Kommuniqué III

Liebe Aktionäre, Freunde,Die außergewöhnlichen Zeiten, in denen wir leben, haben alle Kontinente beeinflusst. Jedes verlorene Leben war eins zu viel. Ich kann unseren italienischen medizinischen Kollegen, Patienten und Familien, die mit der Tragödie kämpfen, nicht …

Download PDF
 
Tuesday, 19 May 2020

CLINUVEL Newsletter

Dear shareholders, friends,The extraordinary times in which we are living have affected all continents. Each life lost has been one too many. I cannot express enough empathy to our Italian medical colleagues, patients and families …

Download PDF